The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
Open accessAbstract
BACKGROUND: Alterations in circulating soluble fms-like tyrosine kinase 1 (sFlt1), an antiangiogenic protein, and placental growth factor (PlGF), a proangiogenic protein, appear to be involved in the pathogenesis of preeclampsia. Since soluble endoglin, another antiangiogenic protein, acts together with sFlt1 to induce a severe preeclampsia-like syndrome in pregnant rats, we examined whether it is associated with preeclampsia in women. METHODS: We performed a nested case-control study of healthy nulliparous women within the Calcium for Preeclampsia Prevention trial. The study included all 72 women who had preterm preeclampsia (<37 weeks), as well as 480 randomly selected women--120 women with preeclampsia at term (at > or =37 weeks), 120 women with gestational hypertension, 120 normotensive women who delivered infants who were small for gestational age, and 120 normotensive controls who delivered infants who were not small for gestational age. RESULTS: Circulating soluble endoglin levels increased markedly beginning 2 to 3 months before the onset of preeclampsia. After the onset of clinical disease, the mean serum level in women with preterm preeclampsia was 46.4 ng per milliliter, as compared with 9.8 ng per milliliter in controls (P<0.001). The mean serum level in women with preeclampsia at term was 31.0 ng per milliliter, as compared with 13.3 ng per milliliter in controls (P<0.001). Beginning at 17 weeks through 20 weeks of gestation, soluble endoglin levels were significantly higher in women in whom preterm preeclampsia later developed than in controls (10.2 ng per milliliter vs. 5.8 ng per milliliter, P<0.001), and at 25 through 28 weeks of gestation, the levels were significantly higher in women in whom term preeclampsia developed than in controls (8.5 ng per milliliter vs. 5.9 ng per milliliter, P<0.001). An increased level of soluble endoglin was usually accompanied by an increased ratio of sFlt1:PlGF. The risk of preeclampsia was greatest among women in the highest quartile of the control distributions for both biomarkers but not for either biomarker alone. CONCLUSIONS: Rising circulating levels of soluble endoglin and ratios of sFlt1:PlGF herald the onset of preeclampsia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maynard, S. E., Min, J.-Y., Merchan, J., Lim, K.-H., Li, J., Mondal, S., Libermann, T. A., Morgan, J. P., Sellke, F. W., Stillman, I. E., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17189 · Cited by 4,101
Self-citationCirculating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Self-citationA Reversible Posterior Leukoencephalopathy Syndrome
Hinchey, J., Chaves, C., Appignani, B., Breen, J., Pao, L., Wang, A., Pessin, M. S., Lamy, C., Mas, J.-L., & Caplan, L. R. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602223340803 · Cited by 3,340
Yang, J. C., Haworth, L., Sherry, R. M., Hwu, P., Schwartzentruber, D. J., Topalian, S. L., Steinberg, S. M., Chen, H. X., & Rosenberg, S. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021491 · Cited by 2,697
Latest Advances in Understanding Preeclampsia
Redman, C. W., & Sargent, I. L. (2005) · Science · doi:10.1126/science.1111726 · Cited by 2,607
Preeclampsia: an endothelial cell disorder
Roberts, J. M., Taylor, R. N., Musci, T. J., Rodgers, G. M., Hubel, C. A., & McLaughlin, M. K. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90665-0 · Cited by 1,859
Soluble endoglin contributes to the pathogenesis of preeclampsia
Venkatesha, S., Toporsian, M., Lam, C., Hanai, J.-I., Mammoto, T., Kim, Y. M., Bdolah, Y., Lim, K.-H., Yuan, H.-T., Libermann, T. A., et al. (2006) · Nature Medicine · doi:10.1038/nm1429 · Cited by 1,855
Self-citationSibai, B., Dekker, G., & Kupferminc, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17987-2 · Cited by 1,814
Self-citationCheifetz, S., Bellón, T., Calés, C., Vera, S., Bernabeu, C., Massagué, J., & Letarte, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41732-2 · Cited by 836
Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis
Heeschen, C., Jang, J. J., Weis, M., Pathak, A., Kaji, S., Hu, R. S., Tsao, P. S., Johnson, F. L., & Cooke, J. P. (2001) · Nature Medicine · doi:10.1038/89961 · Cited by 800
Cited by
Gestational Hypertension and Preeclampsia
(2020) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003891 · Cited by 2,949
Rana (2019) · doi:10.1161/circresaha.118.313276 · Cited by 2,095
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
Zeisler, H., Llurba, E., Chantraine, F., Vatish, M., Staff, A. C., Sennström, M., Olovsson, M., Brennecke, S. P., Stepan, H., Allegranza, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1414838 · Cited by 1,783
The “Great Obstetrical Syndromes” are associated with disorders of deep placentation
Brosens, I., Pijnenborg, R., Vercruysse, L., & Romero, R. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.08.009 · Cited by 1,568
Self-citationPre-eclampsia: pathogenesis, novel diagnostics and therapies
Phipps, E. A., Thadhani, R., Benzing, T., & Karumanchi, S. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0119-6 · Cited by 1,191
Self-citationREVIEW ARTICLE: Th1/Th2/Th17 and Regulatory T‐Cell Paradigm in Pregnancy
Saito, S., Nakashima, A., Shima, T., & Ito, M. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00852.x · Cited by 1,109
Powe, C. E., Levine, R. J., & Karumanchi, S. A. (2011) · Circulation · doi:10.1161/circulationaha.109.853127 · Cited by 967
Self-citationPre-eclampsia part 1: current understanding of its pathophysiology
Chaiworapongsa, T., Chaemsaithong, P., Yeo, L., & Romero, R. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.102 · Cited by 956
Self-citationChappell, L. C., Cluver, C. A., Kingdom, J., & Tong, S. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32335-7 · Cited by 925
Properties of the Glomerular Barrier and Mechanisms of Proteinuria
Haraldsson, B., Nyström, J., & Deen, W. M. (2008) · Physiological Reviews · doi:10.1152/physrev.00055.2006 · Cited by 909
Placental Origins of Preeclampsia: Challenging the Current Hypothesis
Huppertz, B. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.107607 · Cited by 893
Lees, C. C., Stampalija, T., Baschat, A. A., da Silva Costa, F., Ferrazzi, E., Figueras, F., Hecher, K., Kingdom, J., Poon, L. C., Salomon, L. J., et al. (2020) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.22134 · Cited by 886
(2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003018 · Cited by 878
Young, B. C., Levine, R. J., & Karumanchi, S. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102149 · Cited by 719
Self-citationRomero, R., Nien, J. K., Espinoza, J., Todem, D., Fu, W., Chung, H., Kusanovic, J. P., Gotsch, F., Erez, O., Mazaki-Tovi, S., et al. (2008) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050701830480 · Cited by 675
Self-citationAngiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia
Rana, S., Powe, C. E., Salahuddin, S., Verlohren, S., Perschel, F. H., Levine, R. J., Lim, K.-H., Wenger, J. B., Thadhani, R., & Karumanchi, S. A. (2012) · Circulation · doi:10.1161/circulationaha.111.054361 · Cited by 668
Role of transforming growth factor-β superfamily signaling pathways in human disease
Gordon, K. J., & Blobe, G. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.01.006 · Cited by 641
TGF-β signaling in vascular biology and dysfunction
Goumans, M.-J., Liu, Z., & ten Dijke, P. (2009) · Cell Research · doi:10.1038/cr.2008.326 · Cited by 601
RETIRED: Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy
Magee, L. A., Helewa, M., Rey, E., Cardew, S., Côté, A.-M., Douglas, M. J., Firoz, T., Gibson, P. S., Gruslin A., A., Lange, I., et al. (2008) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32776-1 · Cited by 578
Gilbert, J. S., Ryan, M. J., LaMarca, B. B., Sedeek, M., Murphy, S. R., & Granger, J. P. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01113.2007 · Cited by 558
Jung, E., Romero, R., Yeo, L., Gomez-Lopez, N., Chaemsaithong, P., Jaovisidha, A., Gotsch, F., & Erez, O. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.11.1356 · Cited by 552
Self-citationPreeclampsia: The Role of Angiogenic Factors in Its Pathogenesis
Wang, A., Rana, S., & Karumanchi, S. A. (2009) · Physiology · doi:10.1152/physiol.00043.2008 · Cited by 549
Self-citationEndothelium structure and function in kidney health and disease
Jourde-Chiche, N., Fakhouri, F., Dou, L., Bellien, J., Burtey, S., Frimat, M., Jarrot, P.-A., Kaplanski, G., Le Quintrec, M., Pernin, V., et al. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0098-z · Cited by 493
Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice
Zhou, C. C., Zhang, Y., Irani, R. A., Zhang, H., Mi, T., Popek, E. J., Hicks, M. J., Ramin, S. M., Kellems, R. E., & Xia, Y. (2008) · Nature Medicine · doi:10.1038/nm.1856 · Cited by 471
Santner-Nanan, B., Peek, M. J., Khanam, R., Richarts, L., Zhu, E., Fazekas de St Groth, B., & Nanan, R. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901154 · Cited by 469
Developmental origins of metabolic diseases
Hoffman, D. J., Powell, T. L., Barrett, E. S., & Hardy, D. B. (2021) · Physiological Reviews · doi:10.1152/physrev.00002.2020 · Cited by 466
Angiogenic Factors and Preeclampsia
Maynard, S. E., & Karumanchi, S. A. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.10.004 · Cited by 466
Self-citationPineles, B. L., Romero, R., Montenegro, D., Tarca, A. L., Han, Y. M., Kim, Y. M., Draghici, S., Espinoza, J., Kusanovic, J. P., Mittal, P., et al. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.01.008 · Cited by 450
Self-citationPathological aspects of lipid peroxidation
Negre-Salvayre, A., Auge, N., Ayala, V., Basaga, H., Boada, J., Brenke, R., Chapple, S., Cohen, G., Feher, J., Grune, T., et al. (2010) · Free Radical Research · doi:10.3109/10715762.2010.498478 · Cited by 449
Verlohren, S., Herraiz, I., Lapaire, O., Schlembach, D., Moertl, M., Zeisler, H., Calda, P., Holzgreve, W., Galindo, A., Engels, T., et al. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.07.037 · Cited by 448
Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy
Magee, L. A., Pels, A., Helewa, M., Rey, E., & von Dadelszen, P. (2014) · Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health · doi:10.1016/j.preghy.2014.01.003 · Cited by 448
Preeclampsia: Risk Factors, Diagnosis, Management, and the Cardiovascular Impact on the Offspring
Fox, R., Kitt, J., Leeson, P., Aye, C. Y. L., & Lewandowski, A. J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101625 · Cited by 440
Gu, Y., Lewis, D. F., & Wang, Y. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1550 · Cited by 435
An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia
Verlohren, S., Galindo, A., Schlembach, D., Zeisler, H., Herraiz, I., Moertl, M. G., Pape, J., Dudenhausen, J. W., Denk, B., & Stepan, H. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.09.016 · Cited by 428
Shah, D. A., & Khalil, R. A. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.04.012 · Cited by 422
Placental abruption: epidemiology, risk factors and consequences
TIKKANEN, M. (2011) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2010.01030.x · Cited by 421
Negative Regulation of Soluble Flt-1 and Soluble Endoglin Release by Heme Oxygenase-1
Cudmore, M., Ahmad, S., Al-Ani, B., Fujisawa, T., Coxall, H., Chudasama, K., Devey, L. R., Wigmore, S. J., Abbas, A., Hewett, P. W., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.660134 · Cited by 421
Placental Pathology: A Systematic Approach with Clinical Correlations
Redline, R. W. (2008) · Placenta · doi:10.1016/j.placenta.2007.09.003 · Cited by 389
Ji, L., Brkić, J., Liu, M., Fu, G., Peng, C., & Wang, Y.-L. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.12.008 · Cited by 387
Joshi, D., James, A., Quaglia, A., Westbrook, R. H., & Heneghan, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61495-1 · Cited by 385
Verlohren, S., Herraiz, I., Lapaire, O., Schlembach, D., Zeisler, H., Calda, P., Sabria, J., Markfeld-Erol, F., Galindo, A., Schoofs, K., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.01787 · Cited by 372
Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model
Kumasawa, K., Ikawa, M., Kidoya, H., Hasuwa, H., Saito-Fujita, T., Morioka, Y., Takakura, N., Kimura, T., & Okabe, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011293108 · Cited by 367
Noori, M., Donald, A. E., Angelakopoulou, A., Hingorani, A. D., & Williams, D. J. (2010) · Circulation · doi:10.1161/circulationaha.109.895458 · Cited by 362
The role of the immune system in preeclampsia
Saito, S., Shiozaki, A., Nakashima, A., Sakai, M., & Sasaki, Y. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.02.006 · Cited by 351
Diagnosis and management of atypical preeclampsia-eclampsia
Sibai, B. M., & Stella, C. L. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.07.048 · Cited by 350
Self-citationPilot Study of Extracorporeal Removal of Soluble Fms-Like Tyrosine Kinase 1 in Preeclampsia
Thadhani, R., Kisner, T., Hagmann, H., Bossung, V., Noack, S., Schaarschmidt, W., Jank, A., Kribs, A., Cornely, O. A., Kreyssig, C., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.034793 · Cited by 346
Self-citationElevated Blood Pressure in Pregnancy and Subsequent Chronic Disease Risk
Männistö, T., Mendola, P., Vääräsmäki, M., Järvelin, M.-R., Hartikainen, A.-L., Pouta, A., & Suvanto, E. (2013) · Circulation · doi:10.1161/circulationaha.112.128751 · Cited by 340
Rana, S., Burke, S. D., & Karumanchi, S. A. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.10.022 · Cited by 335
Self-citationPreeclampsia and Angiogenic Imbalance
Maynard, S., Epstein, F. H., & Karumanchi, S. A. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.110106.214058 · Cited by 332
Self-citationEndoglin in angiogenesis and vascular diseases
ten Dijke, P., Goumans, M.-J., & Pardali, E. (2008) · Angiogenesis · doi:10.1007/s10456-008-9101-9 · Cited by 327
Abildgaard, U., & Heimdal, K. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2012.09.026 · Cited by 325
Gilbert, J. S., Babcock, S. A., & Granger, J. P. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.096594 · Cited by 324
Molecular mechanisms of preeclampsia
Mutter, W. P., & Karumanchi, S. A. (2008) · Microvascular Research · doi:10.1016/j.mvr.2007.04.009 · Cited by 314
Self-citationPrediction and Prevention of Recurrent Preeclampsia
Barton, J. R., & Sibai, B. M. (2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181801d56 · Cited by 309
Self-citationThe role of decidual immune cells on human pregnancy
Liu, S., Diao, L., Huang, C., Li, Y., Zeng, Y., & Kwak-Kim, J. Y. H. (2017) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2017.10.045 · Cited by 308
A Comprehensive Review of Hypertension in Pregnancy
Mustafa, R., Ahmed, S., Gupta, A., & Venuto, R. C. (2012) · Journal of Pregnancy · doi:10.1155/2012/105918 · Cited by 308
A leading role for the immune system in the pathophysiology of preeclampsia
Laresgoiti-Servitje, E. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1112603 · Cited by 308
SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014
Lowe, S. A., Bowyer, L., Lust, K., McMahon, L. P., Morton, M., North, R. A., Paech, M., & Said, J. M. (2015) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12399 · Cited by 299
Ogge, G., Chaiworapongsa, T., Romero, R., Hussein, Y., Kusanovic, J. P., Yeo, L., Kim, C. J., & Hassan, S. S. (2011) · Journal of Perinatal Medicine · doi:10.1515/jpm.2011.098 · Cited by 299
Self-citationFeldman, D. R., Baum, M. S., Ginsberg, M. S., Hassoun, H., Flombaum, C. D., Velasco, S., Fischer, P., Ronnen, E., Ishill, N., Patil, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.0108 · Cited by 298
Potential markers of preeclampsia – a review
Grill, S., Rusterholz, C., Zanetti-Dällenbach, R., Tercanli, S., Holzgreve, W., Hahn, S., & Lapaire, O. (2009) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-7-70 · Cited by 293
Ilekis, J. V., Tsilou, E., Fisher, S., Abrahams, V. M., Soares, M. J., Cross, J. C., Zamudio, S., Illsley, N. P., Myatt, L., Colvis, C., et al. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.03.001 · Cited by 292
Vascular biology of preeclampsia
Myatt, L., & Webster, R. P. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03259.x · Cited by 292
Erez, O., Romero, R., Espinoza, J., Fu, W., Todem, D., Kusanovic, J. P., Gotsch, F., Edwin, S., Nien, J. K., Chaiworapongsa, T., et al. (2008) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050802034545 · Cited by 287
“Longitudinal studies have demonstrated that these changes precede the development of clinical disease or delivery of an SGA neonate [57] [12,14,17,21].”
BackgroundSelf-citationSequential Changes in Antiangiogenic Factors in Early Pregnancy and Risk of Developing Preeclampsia
Rana, S., Karumanchi, S. A., Levine, R. J., Venkatesha, S., Rauh-Hain, J. A., Tamez, H., & Thadhani, R. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.087700 · Cited by 286
Self-citationPreeclampsia and eclampsia: the conceptual evolution of a syndrome
Erez, O., Romero, R., Jung, E., Chaemsaithong, P., Bosco, M., Suksai, M., Gallo, D. M., & Gotsch, F. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.12.001 · Cited by 282
Self-citationTomimatsu, T., Mimura, K., Matsuzaki, S., Endo, M., Kumasawa, K., & Kimura, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174246 · Cited by 277
Kusanovic, J. P., Romero, R., Chaiworapongsa, T., Erez, O., Mittal, P., Vaisbuch, E., Mazaki-Tovi, S., Gotsch, F., Edwin, S. S., Gomez, R., et al. (2009) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767050902994754 · Cited by 275
Self-citationMatrix Metalloproteinases in Normal Pregnancy and Preeclampsia
Chen, J., & Khalil, R. A. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.04.001 · Cited by 274
Matrix Metalloproteinase-14 (MT1-MMP)–Mediated Endoglin Shedding Inhibits Tumor Angiogenesis
Hawinkels, L. J. A. C., Kuiper, P., Wiercinska, E., Verspaget, H. W., Liu, Z., Pardali, E., Sier, C. F. M., & ten Dijke, P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4466 · Cited by 270
Robust Early Pregnancy Prediction of Later Preeclampsia Using Metabolomic Biomarkers
Kenny, L. C., Broadhurst, D. I., Dunn, W., Brown, M., North, R. A., McCowan, L., Roberts, C., Cooper, G. J. S., Kell, D. B., & Baker, P. N. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.157297 · Cited by 269
Heme Oxygenase-1 and the Vascular Bed: From Molecular Mechanisms to Therapeutic Opportunities
Loboda, A., Jazwa, A., Grochot-Przeczek, A., Rutkowski, A. J., Cisowski, J., Agarwal, A., Jozkowicz, A., & Dulak, J. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2043 · Cited by 265
Stepan, H., Herraiz, I., Schlembach, D., Verlohren, S., Brennecke, S., Chantraine, F., Klein, E., Lapaire, O., Llurba, E., Ramoni, A., et al. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14799 · Cited by 264
Crispi, F., Llurba, E., Domínguez, C., Martín‐Gallán, P., Cabero, L., & Gratacós, E. (2008) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.5184 · Cited by 263
Wang, K., Ahmad, S., Cai, M., Rennie, J., Fujisawa, T., Crispi, F., Baily, J., Miller, M. R., Cudmore, M., Hadoke, P. W. F., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001631 · Cited by 256
Romero, R., Erez, O., Hüttemann, M., Maymon, E., Panaitescu, B., Conde-Agudelo, A., Pacora, P., Yoon, B. H., & Grossman, L. I. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.06.003 · Cited by 253
Self-citationStepan, H., Galindo, A., Hund, M., Schlembach, D., Sillman, J., Surbek, D., & Vatish, M. (2023) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.26032 · Cited by 245
The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis
Tal, R. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.112.102723 · Cited by 235
Hypertension: Physiology and Pathophysiology
Hall, J. E., Granger, J. P., do Carmo, J. M., da Silva, A. A., Dubinion, J., George, E., Hamza, S., Speed, J., & Hall, M. E. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110058 · Cited by 232
Ishibashi, O., Ohkuchi, A., Ali, M. M., Kurashina, R., Luo, S.-S., Ishikawa, T., Takizawa, T., Hirashima, C., Takahashi, K., Migita, M., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.180232 · Cited by 173
Groom, K. M., & David, A. L. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.565 · Cited by 170
Angiogenic Factors in Preeclampsia: From Diagnosis to Therapy
Karumanchi, S. A. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.06421 · Cited by 163
Self-citationPowers, R. W., Jeyabalan, A., Clifton, R. G., Van Dorsten, P., Hauth, J. C., Klebanoff, M. A., Lindheimer, M. D., Sibai, B., Landon, M., Miodovnik, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013263 · Cited by 162
Self-citationRecent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia
LaMarca, B. D., Gilbert, J., & Granger, J. P. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.108837 · Cited by 142
miR-210 Targets Iron-Sulfur Cluster Scaffold Homologue in Human Trophoblast Cell Lines
Lee, D.-C., Romero, R., Kim, J.-S., Tarca, A. L., Montenegro, D., Pineles, B. L., Kim, E., Lee, J., Kim, S. Y., Draghici, S., et al. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.04.035 · Cited by 135
Self-citationPre‐eclampsia and long‐term health outcomes for mother and infant: an umbrella review
Pittara, T., Vyrides, A., Lamnisos, D., & Giannakou, K. (2021) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16683 · Cited by 125
Management of type 1 diabetes in pregnancy
Feldman, A. Z., & Brown, F. M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0765-z · Cited by 65
Expert review: preeclampsia Type I and Type II.
Yagel, S., Cohen, S. M., Admati, I., Skarbianskis, N., Solt, I., Zeisel, A., Beharier, O., & Goldman-Wohl, D. (2023) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2023.101203 · Cited by 61
Kawashima, A., Koide, K., Ventura, W., Hori, K., Takenaka, S., Maruyama, D., Matsuoka, R., Ichizuka, K., & Sekizawa, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106140 · Cited by 59
Preeclampsia: a view through the danger model
Bonney, E. A. (2007) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2007.03.006 · Cited by 53
Szalai, G., Romero, R., Chaiworapongsa, T., Xu, Y., Wang, B., Ahn, H., Xu, Z., Chiang, P. J., Sundell, B., Wang, R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119547 · Cited by 46
Self-citationSilver, K. L., Conroy, A. L., Leke, R. G. F., Leke, R. J. I., Gwanmesia, P., Molyneux, M. E., Wallace, D. T., Rogerson, S. J., & Kain, K. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024985 · Cited by 43
ARID3A is required for mammalian placenta development
Rhee, C., Edwards, M., Dang, C., Harris, J., Brown, M., Kim, J., & Tucker, H. O. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2016.12.003 · Cited by 42
“Fms-like tyrosine kinase 1 (sFLT-1) and placental growth factor (PlGF) are key among angiogenic and anti-angiogenic and mediators implicated in PE pathology (Levine et al., 2006).”
BackgroundFujita, D., Tanabe, A., Sekijima, T., Soen, H., Narahara, K., Yamashita, Y., Terai, Y., Kamegai, H., & Ohmichi, M. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0027 · Cited by 33
“In addition, although there have been several reports suggesting that hypoxia induces the expression of endoglin in PE (Levine et al .”
BackgroundShiozaki, A., & Saito, S. (2018) · Comprehensive Gynecology and Obstetrics · doi:10.1007/978-981-10-5891-2_1 · Cited by 28
Oggè, G., Romero, R., Kusanovic, J. P., Chaiworapongsa, T., Dong, Z., Mittal, P., Vaisbuch, E., Mazaki-Tovi, S., Gonzalez, J. M., Yeo, L., et al. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767050903366119 · Cited by 25
Self-citation
Metadata
- Authors
- Levine, R. J., Lam, C., Qian, C., Yu, K. F., Maynard, S. E., Sachs, B. P., Sibai, B. M., Epstein, F. H., Romero, R., Thadhani, R., & Karumanchi, S. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2006-09-07
- Volume
- 355
- Issue
- 10
- Pages
- 992-1005
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2041999129
- Cited by
- 1,802
- References
- 35
- FWCI
- 99.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.